Search filters

List of works by Stanislas Pol

"Empirical" retreatment of patients with chronic hepatitis C who failed a first direct-acting antiviral-based regimen

scientific article

A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients

scientific article

A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients

scientific article published in August 2008

A puzzling case of portal hypertension in a patient with human immunodeficiency and hepatitis C virus co-infection

scientific article published in October 2007

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

scientific article published on July 2011

A true revolution: enhanced motivation of the patient with rapid loss of virus (or rapid negativation of viral load), relationship between viral and histological cure

scientific article published in December 2011

Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort

scientific article published on 25 June 2020

Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study

scientific article published on 16 November 2020

Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients

article

Acute cholestatic hepatitis revealing Mycoplasma pneumoniae infection without lung involvement in an adult patient

scientific article published in February 2009

Acute hepatitis A virus infection without IgM antibodies to hepatitis A virus

scientific article published in April 2011

All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection

scientific article published on 28 May 2014

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

scientific article published on 28 July 2014

An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms

scientific article published on 6 September 2017

An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO Guidelines

scientific article published on 22 March 2016

Anti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices model

scientific article published on July 2016

Antigenic relevance of F protein in chronic hepatitis C virus infection

scientific article published on October 2004

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study

scientific article

Antiviral activity of telaprevir and boceprevir for the treatment of hepatitis C virus infection in treatment-experienced patients ⬇️

scientific article published on December 1, 2011

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study

scientific article

Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection

scientific article published on 4 June 2014

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data

scientific article

Assessment of biopsy-proven liver fibrosis by 2D-shear wave elastography: An individual patient data based meta-analysis

scientific article

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

scientific article published on 17 August 2016

Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).

scientific article published on 28 October 2015

Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection.

scientific article published on 10 March 2012

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial ⬇️

scientific article published on June 12, 2013

Brief communication: case reports of ribavirin treatment for chronic hepatitis E.

scientific article published on 14 June 2010

Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C

scientific article published on 01 September 2008

Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients

scientific article published on 14 November 2015

Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI?

scientific article published on 13 August 2019

Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)

scientific article published on 18 August 2020

Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009.

scientific article published on 27 April 2010

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

scientific article published on May 2007

Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination

scientific article

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs

scientific article

Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine

scientific article

Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients

article

Clinical management of drug-drug interactions in HCV therapy: challenges and solutions

scientific article

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

scientific article published on 11 February 2019

Co-infection HIV/HBV

scientific article published in May 2002

Comparing interferon-free with interferon-based regimens in HCV patients: Rogers phenomenon and Simpson's paradox

scientific article published on 12 November 2019

Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.

scientific article

Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays

scientific article published on 24 February 2017

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study

scientific article published on 03 May 2018

Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).

scientific article published on 11 February 2015

Comprehensive review of telbivudine in pregnant women with chronic hepatitis B.

scientific article published on March 2016

Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation

scientific article published on 14 March 2019

Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition?

scientific article published in November 2002

Current management and recommendations on hepatitis B therapy in HIV-coinfected patients

scientific article

Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders

scientific article

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

scientific article published on 18 June 2012

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

scientific article published on 30 July 2014

Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection

scientific article

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection

scientific article published on 07 October 2015

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).

scientific article published on 28 January 2016

Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life

scientific article

Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus

article

Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus

scientific article

Direct acting antivirals failure: cause and retreatment options

scientific article published on 31 October 2018

Direct and indirect evidence for the reversibility of cirrhosis

article

Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis

scientific article published on 5 March 2017

Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients

scientific article published on 25 March 2018

Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?

scientific article published on 01 March 2019

Distinct CD4+CD8+ Double-Positive T Cells in the Blood and Liver of Patients during Chronic Hepatitis B and C ⬇️

scientific article (publication date: 2011)

Diversity of circulating HBV genomes and impact on viral infection

scientific article published in 2022

Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?

scientific article published on February 2009

Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice

scientific article published on 09 April 2009

Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?

scientific article published in May 2007

Editorial: reciprocal interaction between HCV direct-acting anti-virals (DAA) and hepatocellular carcinoma (HCC)-a negative impact of HCC on sustained virologic response not of DAA on HCC

scientific article published on 01 July 2019

Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.

scientific article published on January 2009

Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.

scientific article published on 21 November 2014

Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin

scientific article

Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.

scientific article

Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients

scientific article published on 01 April 2019

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis

scientific article published on 3 April 2014

Effects of interleukin-2 on hepatitis B vaccination in uraemic patients

Efficacy and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Renal Impairment ⬇️

scientific article published on October 26, 2010

Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis

scientific article

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a

scientific article

Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency

scientific article published in October 2005

Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study

scientific article published on 25 November 2019

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection

scientific article published on 30 October 2013

Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers ⬇️

scientific article published on February 21, 2011

Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection

scientific article published on 16 September 2011

Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection

scientific article published on 12 July 2012

Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled

scientific article published on 30 May 2017

Epidemiology and natural history of hepatitis B

scientific article published in March 2005

Epidemiology update for HCV and HBV in ESRD in France: Still a lot to do.

scientific article published on June 2017

Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)

article

Epidemiology, transmission and screening of viral hepatitis

scientific article

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

scientific article

Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254].

scientific article published in May 2008

Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis

scientific article published on 06 August 2018

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV ⬇️

scientific article published on December 22, 2010

Evidence of HCV recovery after therapy of hepatitis C virus infection by direct acting antivirals

article

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France

scientific article published on 18 April 2020

Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management

Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease

scientific article published in July 2008

Extra hepatic cancers are the leading cause of death in cirrhotic patients achieving HBV control or HCV eradication.

scientific article published on 16 April 2018

Extrahepatic cancers and chronic HCV infection

scientific article published on 17 January 2018

FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

scientific article published on 01 July 2007

FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients

scientific article published on 01 September 2006

Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results

scientific article published on 4 April 2013

Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial.

scientific article published on June 2013

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

scientific article published on May 2015

Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study

scientific article

Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy

scientific article published in April 2009

Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib

scientific article

Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy

scientific article published on 29 July 2019

Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection

scientific article

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.

scientific article published on October 2017

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

scientific article published in January 2018

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

scientific article published on 20 November 2017

Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.

scientific article

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

scientific article published on 5 October 2015

Grazoprevir/elbasvir combination therapy for HCV infection

scientific article published on 17 October 2016

HCV and the kidney

scientific article published on January 2016

HCV in the haemodialysis population: Treat now or later?

scientific article published on 14 November 2019

HCV infection and hemodialysis.

scientific article

HCV virologic response—new nomenclature recommendations ⬇️

scientific article published on August 28, 2012

HCV, ribavirin, and anemia: a new dawn

scientific article published on 20 September 2013

HCV-infected dialysis patients: History is changing

scientific article published on 04 January 2019

HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection.

scientific article

HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms

scientific article published in March 2004

Hepatic activity and mRNA expression of aspartate aminotransferase isoenzymes in alcoholic and nonalcoholic liver disease

Hepatic profile analyses of tipranavir in Phase II and III clinical trials

scientific article

Hepatic steatosis in HIV–HCV coinfected patients: analysis of risk factors

article

Hepatitis B Virus Infection and the Kidney: Renal Abnormalities in HBV Patients, Antiviral Drugs Handling, and Specific Follow-Up

article by Gilbert Deray et al published 2015 in Advances in hepatology

Hepatitis B vaccine and demyelinating diseases: debate and disinformation

scientific article published on 6 February 2009

Hepatitis B virus genotypes and extrahepatic manifestations.

scientific article

Hepatitis B virus genotypes: clinical, epidemiological and therapeutic implications

scientific article published in November 2002

Hepatitis B virus infection and pregnancy

scientific article published on 11 June 2011

Hepatitis C virus and the kidney

scientific article published on 01 February 2019

Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin

scientific article published in November 2005

Hepatitis C virus infection in hemodialysis patients

scientific article published on 09 August 2013

Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.

scientific article

Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection ⬇️

scientific article published on March 28, 2012

Hepatitis C virus: 25 years-old, the end?

scientific article published on 20 November 2013

Hepatitis C: epidemiology, diagnosis, natural history and therapy.

scientific article published on 30 January 2012

Hepatitis E Virus-Induced Primary Cutaneous CD30(+) T cell Lymphoproliferative Disorder

scientific article published on 28 August 2017

Hepatitis e virus infection in sheltered homeless persons, france

scientific article published in June 2012

Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment

scientific article published in July 2004

Hepatitis: HBV vaccine--the first vaccine to prevent cancer

scientific article published on 17 February 2015

High SVR12 with 8-week and 12-week Glecaprevir/Pibrentasvir: Integrated Analysis of HCV Genotype 1-6 Patients Without Cirrhosis

scientific article published on 15 March 2018

High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?

scientific article published in July 2007

High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients

scientific article published on November 2010

Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis

scientific article published in November 2004

Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C.

scientific article published on September 2004

Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial

scientific article published on 17 October 2013

How to optimize HCV therapy in genotype 1 patients with cirrhosis ⬇️

scientific article published on February 1, 2013

Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells

scientific article published on 01 January 2010

Human immunodeficiency virus-associated obliterative portopathy underlies unexplained aminotransferase elevations under antiretrovirals

scientific article published in August 2009

Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease

scientific article published on 31 May 2002

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

scientific article published on 16 December 2011

IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late? ⬇️

scientific article published on February 1, 2012

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing

scientific article published on 04 November 2019

Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.

scientific article

Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection

scientific article published on January 2003

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area

scientific article published on 31 October 2020

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study

scientific article published on 15 December 2015

Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus

scientific article

Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer

scientific article published in March 2004

Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope

scientific article

Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis ⬇️

scientific article published on September 19, 2011

Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.

scientific article published on February 2005

Improving anti-HCV therapy.

scientific article published on October 2006

Improving anti-hepatitis C virus therapy

scientific article published on September 2006

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

scientific article

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs

scientific article published on 19 July 2018

Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective study

scientific article published on 03 October 2018

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death

scientific article published on 13 August 2020

Individualized treatment of hepatitis C virus infection ⬇️

scientific article published on 09 December 2011

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers

scientific article published on 01 October 2004

Influence of liver biopsy on abstinence in alcohol-dependent patients

scientific article published on 11 July 2008

Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies

scientific article published on 09 April 2016

Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth

scientific article published on 18 February 2019

Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study

scientific article published on January 2009

Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection

scientific article published on 29 June 2010

Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 Haplotype

scientific article published on 01 April 2011

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.

scientific article published on 7 September 2016

Intrahepatic hepatitis C virus RNA quantification in microdissected hepatocytes

scientific article published in April 2004

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

scientific article published in December 2006

Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography.

scientific article published on 22 September 2014

Is stronger better in curing hepatitis C virus infection?

scientific article published on October 2016

Kinetic profiles and management of hepatitis B virus reactivation in patients with immune-mediated inflammatory diseases

scientific article published on September 2013

Late presentation of chronic viral hepatitis for medical care: a consensus definition

scientific article

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

scientific article published on 9 May 2015

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).

scientific article published on 13 March 2015

Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure ⬇️

scientific article published on January 12, 2013

Long-Term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis

Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens

scientific article published on 21 September 2017

Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis

scientific article

Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study

scientific article

MRI presentation of hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH)

scientific article published on 07 September 2019

Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study

scientific article published on 4 August 2010

Management of HBV in immunocompromised patients ⬇️

scientific article published on February 1, 2013

Management of HCV-HIV patients

scientific article published in August 2007

Management of chronic hepatitis C virus infection in HIV-infected patients

scientific article published on July 2008

Management of hepatitis C virus infection in heavy drinkers

scientific article published on 21 March 2013

Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure

scientific article published on 27 September 2015

Micro-elimination of hepatitis C virus

scientific article published on 01 February 2020

Mortality associated with the treatment of HCV with direct-acting antivirals

scientific article published on 23 March 2017

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

scientific article published in August 2003

Mycophenolate sodium-induced hepatotoxicity: first report

scientific article published on 01 August 2006

N-acetylcysteine for paracetamol poisoning: effect on prothrombin

scientific article published in October 2002

NNRTI-related or -unrelated hepatotoxicity?

article

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection

scientific article published on 21 November 2005

Natural history of hepatitis B infection

scientific article published in February 2006

New developments in ultrasound imaging for chronic liver diseases: from anatomic imaging to structural and functional imaging ⬇️

scientific article published on 05 December 2011

New treatments of chronic hepatitis C

scientific article published on 6 November 2011

New trends in hepatitis C management.

scientific article published on 13 January 2010

Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients

scientific article published on 01 January 2007

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir).

scientific article published on 27 June 2016

Non-virological factors are drivers of Hepatocellular Carcinoma in virosuppressed Hepatitis B cirrhosis: results of ANRS CO12 CirVir cohort

scientific article published on 16 January 2019

Nonalcoholic fatty liver disease and HIV infection

scientific article published on May 2012

Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients.

scientific article published on 20 July 2011

Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes

scientific article published on 01 February 2020

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

scientific article published on 31 March 2015

Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)

Optimizing treatment outcomes in chronic hepatitis C: management of non-response

scientific article published on January 2006

Pathological evolution of hepatitis C virus-“Healthy carriers”

scientific article (publication date: 28 June 2008)

Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?

scientific article published on September 2015

Patients with chronic hepatitis B should be screened for hepatocellular carcinoma regardless of liver stiffness measurement

scientific article published on 23 May 2015

PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

scientific article

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

scientific article

Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status

scientific article published on 29 June 2020

Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment

scientific article published on 18 May 2011

Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for eight weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis

scientific article published on 08 May 2020

Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy

scientific article published on 23 January 2015

Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients

scientific article (publication date: October 2007)

Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C.

scientific article published on 29 September 2008

Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging

scientific article published on 15 September 2015

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

scientific article published on 11 November 2010

Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers

scientific article published on 01 October 2020

Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy

scientific article published on 17 July 2008

Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus

scientific article

Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.

scientific article published on 3 March 2014

Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B v

scientific article published on 9 August 2016

Prevention of the mother-to-child transmission of Hepatitis B virus

scientific article published on 01 July 2018

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline

scientific article published on 24 September 2019

Production of hepatitis B defective particles is dependent on liver status.

scientific article published on 2 June 2012

Prognosis assessment of alcoholic liver disease: how and why?

scientific article published on 17 October 2013

Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020

scientific article published on 14 May 2021

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients

scientific article published on 07 November 2017

Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors

scientific article published in March 2008

Protease inhibitor‐based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver ⬇️

scientific article published on August 14, 2012

Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage

Randomized Study of Asunaprevir plus Pegylated Interferon-α and Ribavirin for Previously Untreated Genotype 1 Chronic Hepatitis C ⬇️

scientific article published on June 26, 2013

Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin.

scientific article published on 18 September 2014

Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C.

scientific article published on 16 July 2014

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

scientific article published on 26 October 2013

Rapid and early virological response to chronic hepatitis C treatment with IFN 2b or PEG-IFN 2b plus ribavirin in HIV/HCV co-infected patients

scientific article

Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers

scientific article published on 8 March 2012

Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response

scientific article published on 27 December 2013

Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment.

scientific article published on April 2015

Reply to "Precision-cut human liver slice cultures as an immunological platform"

scientific article published on 24 June 2020

Reply to: “Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection” ⬇️

scientific article published on December 2, 2012

Response to Schiano et al. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV

scientific article published on 01 March 2008

Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.

scientific article

Results From the Phase 2 PEARL-I Study: Interferon-Free Regimens of ABT-450/r + ABT-267 With or Without Ribavirin in Patients With HCV Genotype 4 Infection ⬇️

scholarly article

Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE.

scientific article published on 25 October 2017

Reversibility of cirrhosis in HIV/HBV coinfection

scientific article published on 01 January 2007

Reversibility of hepatitis C virus-related cirrhosis

scientific article published on January 2004

Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib

scientific article

Ribavirin for chronic hepatitis E virus infection in transplant recipients

scientific article

Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin

scientific article published in July 2008

Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients

scientific article published in June 2008

Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy

scientific article

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.

scientific article

Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosis

scientific article published in October 2007

Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study

scientific article published on 2 June 2014

SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.

scientific article published in June 2009

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients

scientific article published on 10 September 2016

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

article

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

scientific article published on 04 October 2019

Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment

scientific article published on January 2009

Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma

scientific article (publication date: 2012)

Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study

scientific article published in February 2007

Serum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV Genotype

scientific article

Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients

scientific article published in July 2008

Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C.

scientific article published on January 2007

Severe evolution of chronic hepatitis C in renal transplantation: a case control study ⬇️

scientific article published on 01 January 2002

Severe skin rash in case of readministration of telaprevir in a patient who previously experienced a non severe rash

scientific article published on 01 June 2012

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

scientific article published in January 2006

Sexually transmitted hepatitis C virus superinfection in HIV/hepatitis C virus co-infected men who have sex with men.

scientific article published on March 2008

Shear wave dispersion for fibrosis, steatosis and activity staging

Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).

scientific article published on 17 March 2014

Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infection

scientific article published on 11 May 2018

Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed

scientific article published on 20 May 2015

Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study

scientific article

Sofosbuvir-based regimens are suboptimal in patients with genotype 2 chronic hepatitis C infection: Real-life experience from the HEPATHER ANRS CO22 cohort

scientific article published on 21 May 2020

Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment

scientific article published on 11 November 2005

Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy

scientific article published on 19 July 2007

Study of the Humoral Immune Response towards HCV Genotype 4 Using a Bead-Based Multiplex Serological Assay

Sustained virologic response rates with telaprevir by response after 4weeks of lead-in therapy in patients with prior treatment failure ⬇️

scientific article published on November 23, 2012

Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a

scientific article

TNF alpha antagonist therapy and safety monitoring

scientific article published on May 2011

Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib?

scientific article published on 01 November 2011

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

scientific article published on April 2009

Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.

scientific article published in March 2018

The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients

scientific article published in September 2005

The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C

scientific article published on 22 August 2019

The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis

scientific article published in March 2003

The impact of haematopoietic growth factors on the management and efficacy of antiviral treatment in patients with hepatitis C virus

scientific article published in January 2005

The impact of human immunodeficiency virus on viral hepatitis

scientific article published on January 2011

The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study

scientific article published on 9 June 2015

The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting

scientific article published on 18 January 2008

The remarkable history of the hepatitis C virus

scientific article published on 25 April 2019

The remarkable history of the hepatitis C virus

scientific article published on 01 June 2019

The role of adherence in virological suppression in patients receiving anti-HBV analogues

scientific article published on 03 November 2011

Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study

scientific article published on 22 January 2015

Therapeutic vaccination in chronic hepatitis B virus carriers

scientific article published on October 2006

Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?

scientific article

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response

scientific article published on 23 May 2019

Tocilizumab: therapy and safety management

scientific article published on 17 June 2010

Transmission of Hepatitis E Virus by Plasma Exchange: A Case Report

scientific article

Transmission of hepatitis E virus with plasma exchange in kidney-transplant recipients: a retrospective cohort study

scientific article published on 20 March 2018

Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial

scientific article published on 15 November 2016

Treatment of HBV-related cirrhosis

scientific article published on June 2009

Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study

scientific article published on 9 November 2010

Treatment of chronic hepatitis B virus infection and hepatocellular carcinoma prevention

scientific article published on 7 September 2015

Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance

scientific article published in April 2002

Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin

scientific article published on July 2009

Treatment of hepatitis C virus genotype 3-infection

scientific article published on February 2014

Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006.

scientific article published on 2 October 2007

Treatment of hepatitis C virus infection

scientific article published on 30 November 2020

Treatment of hepatitis C: current status and perspectives

scientific article published in May 2014

Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in "special populations".

scientific article published in February 2018

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

scientific article published on 10 May 2013

Two-dimensional real-time shear wave elastography and risk for de novo hepatocellular carcinoma in patients with advanced chronic liver disease

scientific article published in 2020

Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease

scientific article published in 2021

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection

scientific article

Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1.

scientific article

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy

scientific article published on 13 February 2019

Veno-occlusive disease of the liver in renal transplant patients

scientific article published in August 2003

Viral hepatitis and the kidney ⬇️

scientific article published on August 6, 2013

Viral hepatitis in solid organ transplantation other than liver.

scientific article published on 15 January 2011

Viral hepatitis, diagnosis, natural history and treatment

scientific article

Viral hepatitis: major progress

scientific article published on 01 January 2011

Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study

scientific article published on May 2015

What happens after hepatitis C eradication?

scientific article published on 25 May 2012

Why actively promote vaccination in patients with cirrhosis?

scientific article published on 04 June 2009

[Assessment and reversibility of liver fibrosis in viral hepatitis]

scientific article published on 01 January 2011

[Atheroma and hepatitis C virus]

scientific article published on 01 November 2002

[Editorial]

[Elimination of hepatitis C virus infection]

scientific article published on 01 January 2019

[Epidemiology of non-alcoholic steatohepatitis. Extent/burden of the problem and its impact on public health]

scientific article published on 19 November 2019

[FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients]

scientific article published on 22 November 2019

[Hepatitis B remains a public health problem in France]

scientific article published on 01 March 2010

[Hepatitis C facing the challenge of healing]

scientific article published on 01 March 2018

[Hepatitis virus infection: key messages]

scientific article published on 01 March 2018

[Impact of resistance to analogue antivirals and therapeutic strategies in situations of dialysis, kidney transplantation, vasculitis, and preemptive treatments in immunosuppressed patients]

scientific article published on 01 October 2006

[Late presentation of Wilson's disease as cirrhosis complicating hepatocellular carcinoma]

scientific article published on 01 January 2003

[Liver and ageing: clinical aspects]

scientific article published on 01 May 2003

[Liver and antiretrovirals: hepatotoxicity, steatosis and monitoring of patients with liver disease]

scientific article published on 01 October 2007

[New recommendations for diagnosis and virological monitoring of viral hepatitis]

scientific article published on 01 January 2003

[The hepatologist and human immunodeficiency virus (HIV): 20 years later...].

scientific article published on 01 October 2007

[The irreversibility of cirrhosis: "the jostle dogma"]

scientific article published on 01 September 2005

[Treatment of delta (type D) hepatitis]

scientific article published on 01 April 2005

[Treatment of hepatitis B. Current strategies]

scientific article published on 01 March 2007

[Treatment of hepatitis C]

scientific article published on 01 January 2011

[Viral hepatitis. Biological hepatic anomalies in an asymptomatic patient]

scientific article published on 01 September 2002

[Viral hepatitis: vaccinate and screen?]

scientific article published on 01 March 2018

Paulina is supported by:

About Paulina

Help